HAVN Life Logo White

The Future of Psychedelic Medicine

Our Story

Find out what inspires us to support mental health disorders.

Our Mission

Supporting innovative therapies to help humans thrive.

Our Team

Multi-disciplinary collaboration
creating positive experiences and outcomes.


Using evidence-informed research, we want to unlock human performance and empower people to achieve their full potential.


Psychedelic medicine is the frontier of mental health and wellness

Social attitudes and behaviours towards mental health are shifting away from pharmaceuticals in favour of sustainably resourced compounds derived from fungi and plant medicines.

350 Million

People globally are affected by a form of depression.

1 Trillion

Dollars lost annually in global workforce productivity due to depression and anxiety.


Formulas standardized across clinical studies of psychedelic compounds.

HAVN Life is part of a global community taking an active role in formulations and research for microdosing therapies which have shown effectiveness in addressing mental health and performance.

Press Releases

HAVN Life Announces Supply and Distribution MOU with Mycrodose Therapeutics

The partnership is a integral step in the The Company’s path to market in the U.S., achieving one of its most important milestones to-date Vancouver, …

Read More →
Press Releases

HAVN Life Announces Distribution Deal with Horizon Grocery + Wellness

This new partnership, along with Well.ca, will help the HAVN Life natural health product line reach new customers and expand sales Vancouver, BC – Havn …

Read More →
Press Releases

HAVN Life Signs Agreement to Supply Psilocybin for Mycotopia Therapies

The partnership will further industry growth for naturally derived psilocybin Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” …

Read More →
Scroll to Top